Lipocine
LPCN
#9691
Rank
HK$0.45 B
Marketcap
HK$81.64
Share price
15.95%
Change (1 day)
128.46%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: HK$0.45 Billion

As of January 2026 Lipocine has a market cap of HK$0.45 Billion. This makes Lipocine the world's 9691th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.45 B100.61%
2025HK$0.22 B14.32%
2024HK$0.19 B70.62%
2023HK$0.11 B-57.89%
2022HK$0.27 B-59.68%
2021HK$0.68 B-1.47%
2020HK$0.69 B513.62%
2019HK$0.11 B-48.99%
2018HK$0.22 B-61.17%
2017HK$0.56 B9.32%
2016HK$0.52 B-71.5%
2015HK$1.82 B250.27%
2014HK$0.52 B-35.59%
2013HK$0.81 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Lipocine was reported to be:

HK$0.45 Billion
by Nasdaq info icon info icon
HK$0.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
HK$336.47 B 74,140.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$76.95 B 16,879.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
HK$81.29 M-82.06%๐Ÿ‡บ๐Ÿ‡ธ USA